These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor]. Zhang P, Zeng X, Gao J, Liu W, Shuai X, Liu K, Liu X, Cai M, Cai K, Wang G, Tao K. Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov 25; 19(11):1290-1295. PubMed ID: 27928802 [Abstract] [Full Text] [Related]
12. Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study. Sun X, Lin X, Zhang Q, Li C, Shu P, Gao X, Shen K. Cancer Med; 2024 Sep 25; 13(18):e70237. PubMed ID: 39300931 [Abstract] [Full Text] [Related]
13. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis. Wang J, Yin Y, Shen C, Yin X, Cai Z, Pu L, Fu W, Wang Y, Zhang B. Medicine (Baltimore); 2020 Feb 25; 99(9):e19275. PubMed ID: 32118738 [Abstract] [Full Text] [Related]
15. Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS). Rubió-Casadevall J, Martinez-Trufero J, Garcia-Albeniz X, Calabuig S, Lopez-Pousa A, Del Muro JG, Fra J, Redondo A, Lainez N, Poveda A, Valverde C, De Juan A, Sevilla I, Casado A, Andres R, Cruz J, Martin-Broto J, Maurel J, Spanish Group for Research on Sarcoma (GEIS). Ann Surg Oncol; 2015 Sep 25; 22(9):2948-57. PubMed ID: 25608769 [Abstract] [Full Text] [Related]